Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Valeriote

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Medical and Pediatric Oncology|January 1, 1982
Cellular aspects of the action of cytosine arabinosideF Valeriote
Journal of the National Cancer Institute|January 1, 1986
Schedule-dependent cytotoxicity of 5-fluorouracil in miceG Santelli, F Valeriote
Transplantation|April 1, 1976
Quantitation of the immune rejection of allotransplanted AKR leukemic cellsR Ducos, F Valeriote
Journal of the National Cancer Institute|January 1, 1980
In vivo potentiation of 5-fluorouracil cytotoxicity against AKR leukemia by purines, pyrimidines, and their nucleosides and deoxynucleosidesG Santelli, F Valeriote
Cancer Chemotherapy and Pharmacology|January 1, 1986
Schedule-dependent antitumor and toxic effects of thymidine and 5-fluorouracil in AKR and L1210 leukemiasG Santelli, F Valeriote
Journal of the National Cancer Institute|January 1, 1986
MOPC-315 murine plasmacytoma as a model anticancer screen for human multiple myelomaF Valeriote, H Grates
Cancer Research|November 1, 1982
Protection and potentiation of nitrogen mustard cytotoxicity by WR-2721F Valeriote, S Tolen
Cancer Drug Delivery|January 1, 1985
Comparison of cytotoxicity of single dose and infusion of alkylating agentsF Valeriote, T Vietti
Journal of the National Cancer Institute|September 1, 1978
In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in miceG Santelli, F Valeriote
Cell and Tissue Kinetics|January 1, 1983
Extensive proliferative capacity of haematopoietic stem cellsF Valeriote, S Tolen
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Medical and Pediatric Oncology|January 1, 1982
Cellular aspects of the action of cytosine arabinosideF Valeriote
Journal of the National Cancer Institute|January 1, 1986
Schedule-dependent cytotoxicity of 5-fluorouracil in miceG Santelli, F Valeriote
Transplantation|April 1, 1976
Quantitation of the immune rejection of allotransplanted AKR leukemic cellsR Ducos, F Valeriote
Journal of the National Cancer Institute|January 1, 1980
In vivo potentiation of 5-fluorouracil cytotoxicity against AKR leukemia by purines, pyrimidines, and their nucleosides and deoxynucleosidesG Santelli, F Valeriote
Cancer Chemotherapy and Pharmacology|January 1, 1986
Schedule-dependent antitumor and toxic effects of thymidine and 5-fluorouracil in AKR and L1210 leukemiasG Santelli, F Valeriote
Journal of the National Cancer Institute|January 1, 1986
MOPC-315 murine plasmacytoma as a model anticancer screen for human multiple myelomaF Valeriote, H Grates
Cancer Research|November 1, 1982
Protection and potentiation of nitrogen mustard cytotoxicity by WR-2721F Valeriote, S Tolen
Cancer Drug Delivery|January 1, 1985
Comparison of cytotoxicity of single dose and infusion of alkylating agentsF Valeriote, T Vietti
Journal of the National Cancer Institute|September 1, 1978
In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in miceG Santelli, F Valeriote
Cell and Tissue Kinetics|January 1, 1983
Extensive proliferative capacity of haematopoietic stem cellsF Valeriote, S Tolen
Pageof 6